Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis?
about
Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticityHost determinants of reinfection with schistosomes in humans: a systematic review and meta-analysisPosttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses.Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidasesHuman IgE responses to different splice variants of Schistosoma mansoni tropomyosin: associations with immunity.Human schistosomiasisEfficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt.Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigensPregnancy and helminth infections.Immunology of human schistosomiasis.Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection.Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates.Non-immune immunoglobulins shield Schistosoma japonicum from host immunorecognition.Cross-reactive immune responses as primary drivers of malaria chronicity.Helminth Allergens, Parasite-Specific IgE, and Its Protective Role in Human Immunity.Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.Allergic Sensitization Underlies Hyperreactive Antigen-Specific CD4+ T Cell Responses in Coincident Filarial Infection.Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population.Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.The Interdependence between Schistosome Transmission and Protective Immunity
P2860
Q28538911-FCE75295-4F88-4A10-9100-EA14ED845700Q28542932-4A4E3936-C519-4631-AF3B-661798D87A95Q33596079-E820F942-8913-4782-B402-EE0B532C31B7Q33611746-D446452F-C2C8-4664-8063-6197F128A2ECQ33634824-17C9676F-6D23-4FE7-BD5F-1074FDE4586EQ34413522-D72B7A60-B9A4-4078-AB46-CD627F8B2079Q34496255-4CB36ABE-C96F-4A43-B9C4-889A10DC0C37Q34563567-B73F7830-14FB-4324-B1B1-06613754AF99Q34658884-BF734406-0DD0-4576-8692-C23BF70EAB5AQ34782228-11D43E02-E1B6-42F2-A321-C6CB83578562Q35042430-D3A67C88-4B83-4DB4-AB71-1B60C9B0CE4AQ35569944-711B0842-E09E-4556-BDF9-F3E253CCC856Q35989513-BA4EF7FF-C0C3-4B62-B71C-3014A8CE4911Q37548076-DC4DD070-98EA-4FDC-BD3C-C990E2C2CEA1Q38193093-190F1B47-94C4-4539-83C8-C8529CD70791Q38978099-586A489B-F8B0-48FF-9AED-E953D2E332B1Q39448421-E42108EA-E8ED-448D-A061-717859AF16A3Q46430580-59BD1FF9-E71A-4B10-AE05-45B369D48BAEQ53697118-EC9423F6-3067-4F73-9054-8012D718F151Q57152572-4AC7325C-1070-4AE1-A06E-BFA93F7EC98A
P2860
Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@ast
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@en
type
label
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@ast
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@en
prefLabel
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@ast
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@en
P2093
P2860
P50
P356
P1476
Progressive cross-reactivity i ...... n immunity to schistosomiasis?
@en
P2093
Colin M Fitzsimmons
Edridah M Tukahebwa
Frances M Jones
Harriet A Dickinson
P2860
P304
P356
10.1128/IAI.00641-12
P407
P577
2012-09-24T00:00:00Z